Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-087255
Filing Date
2016-11-18
Accepted
2016-11-18 16:26:28
Documents
1
Period of Report
2016-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3277
  Complete submission text file 0001140361-16-087255.txt   4777
Mailing Address 660 MADISON AVENUE SUITE 1700 NEW YORK NY 10065
Business Address 660 MADISON AVENUE SUITE 1700 NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KRAMER LEVIN NAFTALIS & FRANKEL LLP 919 THIRD AVENUE SUITE 4000 NEW YORK NY 10022
Business Address
CONSTANCE THOMAS E (Reporting) CIK: 0001139307 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23047 | Film No.: 162008057